Premium
Vaccines against malaria – an update
Author(s) -
Matuschewski Kai,
Mueller AnnKristin
Publication year - 2007
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/j.1742-4658.2007.05998.x
Subject(s) - malaria , immunity , virology , transmission (telecommunications) , malaria vaccine , immune system , biology , immunology , plasmodium falciparum , antigen , plasmodium (life cycle) , medicine , computer science , parasite hosting , telecommunications , world wide web
Malaria vaccine discovery and development follow two principal strategies. Most subunit vaccines are designed to mimic naturally acquired immunity that develops over years upon continuous exposure to Plasmodium transmission. Experimental model vaccines, such as attenuated live parasites and transmission‐blocking antigens, induce immune responses superior to naturally acquired immunity. The promises and hurdles of the different tracks towards an effective and affordable vaccine against malaria are discussed.